|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng R, Zeng H, Zhang S and Chen W:
Estimates of cancer incidence and mortality in China, 2013. Chin J
Cancer. 36:662017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawakami H, Zaanan A and Sinicrope FA:
Implications of mismatch repair-deficient status on management of
early stage colorectal cancer. J Gastrointest Oncol. 6:676–684.
2015.PubMed/NCBI
|
|
5
|
Popat S, Hubner R and Houlston RS:
Systematic review of microsatellite instability and colorectal
cancer prognosis. J Clin Oncol. 23:609–618. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worthley DL, Whitehall VL, Spring KJ and
Leggett BA: Colorectal carcinogenesis: Road maps to cancer. World J
Gastroenterol. 13:3784–3791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sameer AS, Nissar S and Fatima K: Mismatch
repair pathway: Molecules, functions and role in colorectal
carcinogenesis. Eur J Cancer Prev. 23:246–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Korphaisarn K, Pongpaibul A, Limwongse C,
Roothumnong E, Klaisuban W, Nimmannit A, Jinawath A and Akewanlop
C: Deficient DNA mismatch repair is associated with favorable
prognosis in Thai patients with sporadic colorectal cancer. World J
Gastroenterol. 21:926–934. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lindor NM, Burgart LJ, Leontovich O,
Goldberg RM, Cunningham JM, Sargent DJ, Walsh-Vockley C, Petersen
GM, Walsh MD, Leggett BA, et al: Immunohistochemistry versus
microsatellite instability testing in phenotyping colorectal
tumors. J Clin Oncol. 20:1043–1048. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Herman JG, Umar A, Polyak K, Graff JR,
Ahuja N, Issa JP, Markowitz S, Willson JK, Hamilton SR, Kinzler KW,
et al: Incidence and functional consequences of hMLH1 promoter
hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA.
95:6870–6875. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Grady WM and Carethers JM: Genomic and
epigenetic instability in colorectal cancer pathogenesis.
Gastroenterology. 135:1079–1099. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge SB and Compton CC: The American joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Umar A, Boland CR, Terdiman JP, Syngal S,
de la Chapelle A, Rüschoff J, Fishel R, Lindor NM, Burgart LJ,
Hamelin R, et al: Revised bethesda guidelines for hereditary
nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite
instability. J Natl Cancer Inst. 96:261–268. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Compton CC and Greene FL: The staging of
colorectal cancer: 2004 and beyond. CA Cancer J Clin. 54:295–308.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Compton CC, Fielding LP, Burgart LJ,
Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV,
Nagle RB, et al: Prognostic factors in colorectal cancer. College
of American Pathologists Consensus Statement 1999. Arch Pathol Lab
Med. 124:979–994. 2000.PubMed/NCBI
|
|
16
|
Wang LG, Ni Y, Su BH, Mu XR, Shen HC and
Du JJ: MicroRNA-34b functions as a tumor suppressor and acts as a
nodal point in the feedback loop with Met. Int J Oncol. 42:957–962.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ma H, Wang L, Zhang T, Shen H and Du J:
Loss of β-arrestin1 expression predicts unfavorable prognosis for
non-small cell lung cancer patients. Tumour Biol. 37:1341–1347.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bhattacharya P and McHugh TW: Lynch
SyndromeStatPearls. StatPearls Publishing StatPearls Publishing LLC
Treasure Island (FL); 2017
|
|
19
|
Kawakami H, Zaanan A and Sinicrope FA:
Microsatellite instability testing and its role in the management
of colorectal cancer. Curr Treat Options Oncol. 16:302015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Win AK, Young JP, Lindor NM, Tucker KM,
Ahnen DJ, Young GP, Buchanan DD, Clendenning M, Giles GG, Winship
I, et al: Colorectal and other cancer risks for carriers and
noncarriers from families with a DNA mismatch repair gene mutation:
A prospective cohort study. J Clin Oncol. 30:958–964. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sheng JQ, Chan TL, Chan YW, Huang JS, Chen
JG, Zhang MZ, Guo XL, Mu H, Chan AS, Li SR, et al: Microsatellite
instability and novel mismatch repair gene mutations in northern
Chinese population with hereditary non-polyposis colorectal cancer.
Chin J Dig Dis. 7:197–205. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ericson K, Halvarsson B, Nagel J, Rambech
E, Planck M, Piotrowska Z, Olsson H and Nilbert M: Defective
mismatch-repair in patients with multiple primary tumours including
colorectal cancer. Eur J Cancer. 39:240–248. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Herman JG, Merlo A, Mao L, Lapidus RG,
Issa JP, Davidson NE, Sidransky D and Baylin SB: Inactivation of
the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA
methylation in all common human cancers. Cancer Res. 55:4525–4530.
1995.PubMed/NCBI
|
|
24
|
Belvederesi L, Bianchi F, Galizia E,
Loretelli C, Bracci R, Catalani R, Amati M and Cellerino R: MSH2
missense mutations and HNPCC syndrome: Pathogenicity assessment in
a human expression system. Hum Mutat. 29:E296–E309. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Benatti P, Gafa R, Barana D, Marino M,
Scarselli A, Pedroni M, Maestri I, Guerzoni L, Roncucci L,
Menigatti M, et al: Microsatellite instability and colorectal
cancer prognosis. Clin Cancer Res. 11:8332–8340. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ohrling K, Edler D, Hallström M and
Ragnhammar P: Mismatch repair protein expression is an independent
prognostic factor in sporadic colorectal cancer. Acta Oncol.
49:797–804. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Greenson JK, Huang SC, Herron C, Moreno V,
Bonner JD, Tomsho LP, Ben-Izhak O, Cohen HI, Trougouboff P, Bejhar
J, et al: Pathologic predictors of microsatellite instability in
colorectal cancer. Am J Surg Pathol. 33:126–133. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hutchins G, Southward K, Handley K, Magill
L, Beaumont C, Stahlschmidt J, Richman S, Chambers P, Seymour M,
Kerr D, et al: Value of mismatch repair, KRAS and BRAF mutations in
predicting recurrence and benefits from chemotherapy in colorectal
cancer. J Clin Oncol. 29:1261–1270. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sargent DJ, Marsoni S, Monges G, Thibodeau
SN, Labianca R, Hamilton SR, French AJ, Kabat B, Foster NR, Torri
V, et al: Defective mismatch repair as a predictive marker for lack
of efficacy of fluorouracil-based adjuvant therapy in colon cancer.
J Clin Oncol. 28:3219–3226. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sinicrope FA, Foster NR, Thibodeau SN,
Marsoni S, Monges G, Labianca R, Kim GP, Yothers G, Allegra C,
Moore MJ, et al: DNA mismatch repair status and colon cancer
recurrence and survival in clinical trials of 5-fluorouracil-based
adjuvant therapy. J Natl Cancer Inst. 103:863–875. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hemminki A, Mecklin JP, Järvinen H,
Aaltonen LA and Joensuu H: Microsatellite instability is a
favorable prognostic indicator in patients with colorectal cancer
receiving chemotherapy. Gastroenterology. 119:921–928. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Elsaleh H, Joseph D, Grieu F, Zeps N, Spry
N and Iacopetta B: Association of tumour site and sex with survival
benefit from adjuvant chemotherapy in colorectal cancer. Lancet.
355:1745–1750. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sinicrope FA and Yang ZJ: Prognostic and
predictive impact of DNA mismatch repair in the management of
colorectal cancer. Future Oncol. 7:467–474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Carroll PR, Parsons JK, Andriole G,
Bahnson RR, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI,
Etzioni RB, et al: NCCN Guidelines Insights: Prostate cancer early
detection, version 2.2016. J Natl Compr Canc Netw. 14:509–519.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Engstrom PF, Arnoletti JP, Benson AB III,
Chen YJ, Choti MA, Cooper HS, Covey A, Dilawari RA, Early DS,
Enzinger PC, et al: NCCN clinical practice guidelines in oncology:
Colon cancer. J Natl Compr Canc Netw. 7:778–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Benson AB III, Venook AP, Bekaii-Saab T,
Chan E, Chen YJ, Cooper HS, Engstrom PF, Enzinger PC, Fenton MJ,
Fuchs CS, et al: Colon cancer, version 3.2014. J Natl Compr Canc
Netw. 12:1028–1059. 2014. View Article : Google Scholar : PubMed/NCBI
|
